New clinical cleanroom manufacturing and training facility launches in Brisbane

The Hon Karen Andrews, Minister for Industry, Science and Technology is opening the Translational Research Institute’s (TRI) new state-of-the-art clinical cleanroom manufacturing and training facility, T3 Cleanrooms, and the inaugural MTPCareers Symposium on Wednesday 14 October 2020.

The new cleanroom facility will help significantly speed-up the translation of Australian medical innovations into clinical practice, and will be available to researchers, start-ups and companies to manufacture sterile products on a small scale.

Professor Scott Bell, CEO of the TRI says the T3 Cleanroom facility is the outcome of a successful partnership with Australian biotech, Vaxxas Pty Ltd, to secure funding from MTPConnect to build clinical manufacturing and training capacity.

Based in dedicated commercial space at TRI, Vaxxas worked with us to identify a critical gap in medtech manufacturing and skills for companies needing to scale-up production for clinical trials, which led TRI to develop the unique T3 Cleanrooms.”


Professor Scott Bell, CEO of the TRI

Having access to this vital facility is enabling Vaxxas to progress its innovative vaccine technology from preclinical to clinical trials and is a great example of the translational pathway that exists at TRI to foster the commercialisation of Australian medical innovations.

“Importantly, while based at TRI, Vaxxas has secured millions in funding from the US Biomedical Advanced Research and Development Authority (BARDA), Merck and the Bill and Melinda Gates Foundation to support human clinical trials of its micro-patch technology to deliver vaccines worldwide.”

MTPConnect CEO, Dr Dan Grant says the Growth Centre’s funding is improving critical research infrastructure to global standards to help accelerate the translation of new medical innovations, while also boosting the workforce skills of Australia’s new generation of scientists.

“Giving Australian researchers and start-up medtech and pharma companies access to high

Matroid Completes $20 Million Series B Financing to Expand into Manufacturing and Industrial IOT

Matroid, the leading U.S. computer vision (CV) provider and a world leader in machine learning, today announced it has raised $20 million in Series B funding led by Energize Ventures with participation from existing investors New Enterprise Associates (NEA), Intel Capital, and others. The new financing brings total funding to $33.5 million. Building on the enterprise success of its product, Matroid plans to leverage the new funding to accelerate product development and go-to-market expansion in manufacturing, industrial IOT (IIOT), and video security markets. Within manufacturing and IIOT, Energize’s corporate investors include General Electric, Schneider Electric, Caterpillar, Invenergy, and others.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201013005076/en/

Figure: The Matroid product being used to build a detector for wind turbine damage caused by lightning, bird strikes, and rust. (Graphic: Business Wire)

Software-defined sensors that operate on imagery captured by regular cameras are quickly becoming the pinnacle sensor. Sensors are critical for many enterprises, federal agencies, and public safety organizations. But a variety of factors have limited the scope of deployments, including the complexity, corner-cases, and training costs associated with building video and machine learning pipelines of sufficient throughput, in a manner where a deployment can happen in minutes, instead of months. The Matroid product enables non-software organizations in enterprise to harness the power of software-defined sensors. Founded in 2016 by Stanford engineers and professors with world-class expertise in AI, machine learning, and computer Vision, Matroid unlocks the promise of software-defined sensors through unmatched ease of use in the entire deployment lifecycle.

“Enterprises have tasted the value that software-defined sensors can provide, but are also feeling the pain of rolling out a conventional computer vision team,” said Reza Zadeh, CEO and Founder of Matroid. “Deployments of CV are constrained by Machine Learning engineering time, operator training time,

Call for Award Applicants: Johnson & Johnson Seeks Female Researchers Working in Science, Technology, Engineering, Math, Manufacturing and Design | India Education,Education News India,Education News

Mumbai: Johnson & Johnson today announced that it is accepting applications for its 2021 Women in STEM2D (WiSTEM2D) Scholars Award, aimed at supporting assistant or associate academic professors in the disciplines of Science, Technology, Engineering, Math, Manufacturing and Design. For three years, each recipient will receive mentorship from leaders at Johnson & Johnson and a total $150,000 ($50,000 each year). The deadline for applications is Oct. 15, 2020 at 9 a.m. HST, and guidelines and additional details are available here: https://www.jnj.com/wistem2d-university-scholars.

Launched in June 2017, the Johnson & Johnson WiSTEM2D Scholars Award aspires to fuel development of female STEM2D leaders, and inspire career paths in STEM2D, by supporting the research of the awarded women in their respective STEM2D fields.

Dr. Naama Geva-Zatorsky, one of the 2019 winners of the Johnson & Johnson WiSTEM2D Scholars Award, along with her team of researchers at the Technion – Israel Institute of Technology, have developed what they describe as a simple, efficient COVID-19 testing kit where results can be obtained in less than one hour.

“COVID-19 has impacted global communities in so many different ways – in fact, data shows that it has already disproportionately impacted communities of color and women in varying ways, and without strong action it can impede progress on girls and women of all backgrounds entering STEM fields,” said Cat Oyler, Vice President, Vice President, Strategic Initiatives, Janssen Global Services, LLC and WiSTEM2D University Sponsor. “Now more than ever, we remain committed to helping combat this by fostering and supporting female innovators like Dr. Geva-Zatorsky who will lead STEM2D breakthroughs and help change the trajectory of health for humanity.”

An independent External Advisory Board will select the 2021 winners, each of whom will represent one of the STEM2D disciplines. Last year, more than 500 highly qualified applicants from across the

Low cost and ease of manufacturing allow for wide application in developing countries — ScienceDaily

Electrical engineers, computer scientists and biomedical engineers at the University of California, Irvine have created a new lab-on-a-chip that can help study tumor heterogeneity to reduce resistance to cancer therapies.

In a paper published today in Advanced Biosystems, the researchers describe how they combined artificial intelligence, microfluidics and nanoparticle inkjet printing in a device that enables the examination and differentiation of cancers and healthy tissues at the single-cell level.

“Cancer cell and tumor heterogeneity can lead to increased therapeutic resistance and inconsistent outcomes for different patients,” said lead author Kushal Joshi, a former UCI graduate student in biomedical engineering. The team’s novel biochip addresses this problem by allowing precise characterization of a variety of cancer cells from a sample.

“Single-cell analysis is essential to identify and classify cancer types and study cellular heterogeneity. It’s necessary to understand tumor initiation, progression and metastasis in order to design better cancer treatment drugs,” said co-author Rahim Esfandyarpour, UCI assistant professor of electrical engineering & computer science as well as biomedical engineering. “Most of the techniques and technologies traditionally used to study cancer are sophisticated, bulky, expensive, and require highly trained operators and long preparation times.”

He said his group overcame these challenges by combining machine learning techniques with accessible inkjet printing and microfluidics technology to develop low-cost, miniaturized biochips that are simple to prototype and capable of classifying various cell types.

In the apparatus, samples travel through microfluidic channels with carefully placed electrodes that monitor differences in the electrical properties of diseased versus healthy cells in a single pass. The UCI researchers’ innovation was to devise a way to prototype key parts of the biochip in about 20 minutes with an inkjet printer, allowing for easy manufacturing in diverse settings. Most of the materials involved are reusable or, if disposable, inexpensive.

Another

India has Approved Incentives for 16 Smartphone Companies including Apple’s Big Three iPhone Manufacturing Partners

 

In May Patently Apple posted a report titled “The Indian Government has dropped Contentious Clauses in their new ‘Production Linked Incentive’ Program that could be Positive for Apple.” In order to gain from the new Incentive in India, Smartphone companies had to invest in the country in order to tap into the scheme. In late June we reported on Foxconn making a huge investment in an iPhone plant in India. Last week we reported that Pegatron was going to open a plant supporting Apple’s supply chain for cases in 2021 (2 reports, 01 & 02). In August we reported that Wistron was hiring for its third iPhone plant.

 

Today we’re learning that the Indian government has stated that “it was approving incentives under a federal plan to boost domestic smartphone production to 16 companies, including top Apple suppliers Foxconn, Wistron and Pegatron.” The companies invested as requested and now the government is following-up on their promise.

 

2 Wistron's 3rd iPhone plant hires big time

(Click on image to Enlarge)

 

Two sources had told Reuters that these three companies have presented plans to invest a total of almost $900 million in India in the next five years to benefit from the scheme.

 

India’s smartphone industry has become a showpiece for Prime Minister Narendra Modi’s “Make In India” drive. The $6.65 billion incentive scheme is part of the government’s aim to make the country into an export and manufacturing hub.

 

Samsung, which runs the world’s biggest mobile phone manufacturing plant on the outskirts of New Delhi, also got approval, India’s tech ministry said in a statement. For more on this latest news, review the full Reuters report.

 

10.0F - Apple News

Source Article